Teva wins FDA approval for monthly schizophrenia injection Weltruza

Regulatory Approvals — Teva wins FDA approval for monthly schizophrenia injection Weltruza  CNBC

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 10, 2026.

By